NOVEMBER - 20225TECH OUTLOOKDigital InnovationIris Loew-Friedrich, EVP & Chief Medical Officer, UCBCXO INSIGHTSLAST WORDInnovation vs Validation in Early Drug DiscoveryAnalytical Considerations for Combination ProductsJennifer Riter, Sr. Director, Analytical Services, West Pharmaceutical Services, Inc.22Challenges and Opportunities for AI in Drug DiscoveryBobby Prill, Director, Data Science and AI, Computational Biology and Data Sciences, Ferring Research Institute, Inc. and Yong Yue, Senior Director, Computational Biology and Data Sciences, Ferring Research Institute, Inc.26Why Strain Typing Should Be in Your Microbial Control ToolboxJessica Wilson Rayser, Associate Director of Product Management, Charles River Laboratories28C O N TE N TSCarlos Pedraza, PhD, Director of CNS Biology, Alkermes3024Cloud Computing Driving Change in Pharma IndustryChris Braithwaite, SVP and Global Head of Drug Development Technology, Novartis19
< Page 4 | Page 6 >